Ken Vroman - 15 Mar 2026 Form 4 Insider Report for CME GROUP INC. (CME)

Role
Chief Transformation Officer
Signature
By: Margaret Austin Wright For: Kendal L. Vroman
Issuer symbol
CME
Transactions as of
15 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 12:23:41 UTC
Previous filing
12 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Vroman Ken Chief Transformation Officer 20 S. WACKER DRIVE, CHICAGO By: Margaret Austin Wright For: Kendal L. Vroman 17 Mar 2026 0001429863

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CME Common Stock Class A Award +7,076 +47% $311.40* 21,986 15 Mar 2026 Direct F1
transaction CME Common Stock Class A Tax liability -3,135 -14% $311.40* 18,851 15 Mar 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025.
F2 Mr. Vroman surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award.